VitalConnect is redefining patient care with the VitalPatch biosensor debuting at the 2016 HIMSS Conference. With the global market for biosensors to monitor health projected to exceed $40 billion annually by 2020, Vital Connect’s innovative sensor technology defines the next generation of patient monitoring solutions at home and in the hospital. As a leader in medical-grade wearable biosensors combined with mobile and cloud-based technologies, the company is introducing its latest product, the VitalPatch, an all-in-one, single-use, fully disposable wearable developed to support clinical decision-making.
Powered by Vital Connect’s proprietary VitalCore processor, the VitalPatch is the next evolution of Vital Connect’s already best-in-class FDA-approved biosensor, HealthPatch MD. With the VitalPatch, the same powerful continuous measurements available in HealthPatch MD are now included in a peel and stick, single-use device. The lightweight, wireless, adhesive patch continuously monitors and records single lead ECG, heart rate, heart rate variability, respiratory rate, skin temperature, posture, step count and fall detection with clinical accuracy. Through the VitalConnect platform, care teams receive accurate data and notifications to make health decisions and enable timely interventions. With the VitalPatch, patients may be monitored at any location where continuous monitoring offers the opportunity for early detection of patient deterioration and early intervention by care teams.